A history of drug development in four acts

- The future of pharmaceutical discovery is unclear in light of unique trends in marketing and R&D allocations.
- Slowing investment in early-stage discovery raises concerns about pipeline sustainability.
- Decreasing NIH funding threatens the future of academia as a source of innovation.